Bayview Pharmacy is pleased to present our specially compounded vaginal jelly formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026%. This unique formulation is designed to provide effective treatment for a range of gynecological conditions, including Bacterial Vaginosis, Candidiasis, Trichomoniasis, Vulvovaginal Atrophy, and Vulvovaginitis.

The active ingredients in this formulation, Boric Acid and Hydroxyquinoline Sulfate, work synergistically to combat these conditions. Boric Acid serves as an antiseptic and antifungal agent, inhibiting the growth of bacteria and fungi. Hydroxyquinoline Sulfate, on the other hand, is an antimicrobial agent that aids in reducing inflammation and irritation. Together, these ingredients help alleviate the symptoms associated with the aforementioned gynecological conditions.

This gel-like semisolid formulation is dispensed in a tube for easy and controlled application in the vaginal area. It is designed to deliver medication effectively, while also providing lubrication and therapeutic effects. It is important to note that this formulation should not be used for more than 7 consecutive days, and is not recommended for use by pregnant women.

If you have any questions or concerns about this formulation or its application, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to providing you with the necessary information and guidance to ensure you receive the most appropriate treatment for your gynecological condition.

This compounded formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a specialized treatment designed for various gynecological conditions such as Bacterial Vaginosis, Candidiasis, Trichomoniasis, Vulvovaginal Atrophy, and Vulvovaginitis. It is a gel-like semisolid formulation that is dispensed in a tube for easy and controlled application in the vaginal area. The formulation delivers medication while providing lubrication and therapeutic effects.

It is crucial to note that this formulation is not recommended for use in pregnant women due to potential risks to the fetus. Additionally, patients with known hypersensitivity to any of the ingredients should refrain from using this formulation. If any irritation or adverse reactions occur, it is advised to discontinue use immediately and consult with a healthcare provider.

Patients are advised to use this formulation as directed and to avoid contact with the eyes. It is also recommended to use a condom during treatment as this formulation may reduce the effectiveness of latex condoms. Patients are further advised to abstain from sexual intercourse until the infection is completely cleared to prevent transmission.

If symptoms persist or worsen, it is important to contact a healthcare provider for further evaluation and treatment. This formulation is designed to provide relief and treatment for specific gynecological conditions, and proper use is essential for optimal results.

This compounded formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a specialized treatment designed for a range of vaginal conditions. It is particularly effective in treating Bacterial Vaginosis, Candidiasis, Trichomoniasis, Vulvovaginal Atrophy, and Vulvovaginitis. The unique combination of boric acid and hydroxyquinoline sulfate in this formulation works synergistically to alleviate inflammation and irritation, while also offering antifungal and antibacterial properties.

Boric acid in the formulation helps to lower the pH of the vagina, creating an environment that inhibits the growth of harmful bacteria and fungi. Hydroxyquinoline sulfate, on the other hand, contributes to reducing inflammation and irritation, while also providing antifungal and antibacterial properties. This dual-action approach ensures comprehensive treatment and relief from the symptoms associated with these conditions.

The formulation is dispensed in a gel-like semisolid form, specifically designed for easy and controlled application in the vaginal area. This ensures that the medication is delivered directly to the affected area, providing maximum therapeutic effects. It is crucial to follow the instructions provided by your healthcare provider when using this product to ensure its effectiveness and safety.

Please note that this product should not be used if you are pregnant or breastfeeding. If you have any questions about this formulation or how it works, do not hesitate to reach out to your healthcare provider. They are best equipped to provide you with the necessary information and guidance to ensure the best possible treatment for your condition.

This compounded formulation of Boric Acid 1%/Hydroxyquinoline Sulfate 0.026% Vaginal Jelly is a gel-like semisolid substance, specifically designed for easy and controlled application in the vaginal area. It is primarily used for delivering medication and providing lubrication and therapeutic effects for various gynecological purposes.

The formulation is effective in treating conditions such as bacterial vaginosis, candidiasis, trichomoniasis, vulvovaginal atrophy, and vulvovaginitis. However, it is crucial to understand that this formulation should not be used to treat any other conditions apart from those mentioned. It is also not recommended to use this formulation in conjunction with other topical or oral medications.

Patients should be aware that this formulation may cause irritation or a burning sensation upon application. If any of these symptoms occur, it is advised to discontinue use immediately and consult with a healthcare provider. Similarly, prescribers should be cognizant of these potential side effects and advise their patients accordingly.

If you have any queries about this formulation or any other compounding needs, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with all your pharmaceutical needs.